Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
2024 · Leukemia · 6 citations
https://doi.org/10.1038/s41375-024-02180-3
L
Lucie Freiman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
13
Citations
2
h-index
0
i10-index
Lucie Freiman is an academic researcher from Saint Louis University Hospital. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Lymphoma Diagnosis and Treatment & BRCA gene mutations in cancer. The author has an h-index of 2, co-authored 5 publications.
ORCID: 0000-0001-7205-9026Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat